HIV/AIDS

HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication. Read More

Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study. Read More

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease. Read More

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus. Read More

When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs. Read More

When chronic disease patients let their care lapse and fail to show for clinic appointments, it may behoove clinics to reach out and encourage a return to care. Read More

The health of people around the world depends to a large extent on the ability of the global health community to predict what challenges must be met in the future. Read More

Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce. Read More

Vanderbilt University has been awarded a major federal grant — $16 million over four years — to coordinate AIDS education and training efforts in Tennessee and seven other southeastern states. Read More

Vanderbilt University has received a five-year grant from the National Institutes of Health (NIH) to establish the Tennessee Center for AIDS Research with Meharry Medical College and the Tennessee Department of Health. Read More

Third-year Vanderbilt University School of Medicine student Ishan Asokan has been selected as an inaugural member of the Elton John AIDS Foundation (EJAF) Fellowship for students addressing HIV/AIDS and health disparities. Read More

U.S. Ambassador-at-Large Deborah Birx, M.D., who oversees the President’s Emergency Program for AIDS Relief (PEPFAR), updated the Vanderbilt community on AIDS relief efforts during a visit last week. (Photo by John Russell) “Incredible progress” has been made in the fight against AIDS, but in some countries, especially… Read More

The Vanderbilt Comprehensive Care Clinic has received a nearly $54,000 grant for 2014-2015 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS. Read More

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH). Read More

The Vanderbilt Comprehensive Care Clinic has received a nearly $40,000 grant for 2013-2014 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS. Read More

Genetic testing has revolutionized the treatment of patients with HIV/AIDS. But it is not a panacea. Read More

Researchers at the Vanderbilt Institute for Global Health (VIGH) have received a major federal grant to study whether an integrated, family-focused approach can prevent mother-to-child transmission of HIV — the AIDS virus — in Nigeria. Read More

Vanderbilt University’s Vikrant Sahasrabuddhe, M.D., MPH, DrPH, received the IAS/ANRS Young Investigator Award at the International AIDS Conference last week in Washington, D.C. Read More

New details about a host mechanism that fights off HIV may reveal strategies for therapies to treat or prevent HIV infection. Read More

Vanderbilt University researchers are partnering with the Chinese government to test methods for reducing the spread of the AIDS virus among gay men. Read More